379 filings
Page 10 of 19
8-K
df4tfx x8f7
30 Jan 13
Other Events
12:00am
8-K
188gtobg8q7uj3m
23 Jan 13
Entry into a Material Definitive Agreement
12:00am
8-K
193xevds48dwsl
3 Jan 13
Other Events
12:00am
8-K
1fahupr 773w
19 Dec 12
Entry into a Material Definitive Agreement
12:00am
8-K
2oy3hs91 87aukx
12 Dec 12
Other Events
12:00am
8-K
mvw04r2
23 Oct 12
Entry into a Material Definitive Agreement
12:00am
8-K
261wyyy4353x3gy70fz
16 Oct 12
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
zhggaghmfke1 frh
17 Aug 12
Departure of Directors or Certain Officers
12:00am
8-K
h3sbj0r2i95vulwl
3 Aug 12
Entry into a Material Definitive Agreement
12:00am
8-K
ny4pt
30 May 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
nequzm7f
16 Apr 12
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
0macrk6sx setq
30 Mar 12
Departure of Directors or Certain Officers
12:00am
8-K
pj0ryqngrdj
26 Mar 12
Gencarotm’s Norepinephrine Lowering Likely Contributes to Its Effect In Atrial Fibrillation Prevention
12:00am
8-K
3q8htqsefbkn7udywzu
19 Jan 12
Arca Biopharma Announces Additional Patent Issued for Methods for Treatment with Bucindolol Based on Genotype of Patient
12:00am
8-K
2zuzuom5oc
30 Dec 11
Arca Biopharma Announces Additional Patent Issued for Methods
12:00am
8-K/A
ddikl14dpyidir7s
27 Dec 11
Entry into a Material Definitive Agreement
12:00am
8-K
rz17t0c2
22 Dec 11
Arca Biopharma Announces Private Placement of $1.75 Million
12:00am
8-K
lzuv8n nblqpbtzpt4
17 Nov 11
Gencarotm Demonstrated 74% Risk Reduction for New Onset
12:00am
8-K
7hme wrhrih0vvz6v5
14 Nov 11
Other Events
12:00am
8-K
m1pke9uvoz0fh0d
24 Jun 11
Other Events
12:00am